Acknowledgement
Supported by : Chonnam National University Hospital Research Institute of Clinical Medicine
References
- Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967;16:178-222
- Newburger JW, Burns JC. Kawasaki syndrome. Cardiol Clin 1989;7:453-65
- Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics 1978;61:100-7
- Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, et. al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984;2:1055-8
- Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. Treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986;315:341-7 https://doi.org/10.1056/NEJM198608073150601
- Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 2000;105:e78 https://doi.org/10.1542/peds.105.6.e78
- Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C. Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 2003;24:145-8 https://doi.org/10.1007/s00246-002-0216-2
- Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease. J Pediatr 2000;137:177-80 https://doi.org/10.1067/mpd.2000.107890
- Joffe A, Kabani A, Jadavji T. Atypical and complicated Kawasaki disease in infants. Do we need criteria? West J Med 1995;162:322-7
- Fukunishi M, Kikkawa M, Hamana K, Onodera T, Matsuzaki K, Matumoto Y, et al. Prediction of non-response to intravenous high-dose gammaglobulin therapy in patients with Kawasaki disease at onset. J Pediatr 2000;137:172-6 https://doi.org/10.1067/mpd.2000.104815
- Inoue Y, Kobavashi T, Tomomasa T, Morikawa A. Macro creatine kinase in Kawasaki disease. Pediatr Cardiol 1999;20:206-7 https://doi.org/10.1007/s002469900442
- Yun SW. Diagnostic value of serum cardiac Troponin T, Troponin I and CK-MB in acute Kawasaki disease. Korean Circ J 2009;34:582-92
- Engle MA, Fatica NS, Bussel JB, O'Loughlin JE, Snyder MS, Lesser ML. Clinical trial of single-dose intravenous gamma globulin in acute Kawasaki disease. Preliminary reort. Am J Dis Child 1989;143:1300-4
- Ahn SY, Hong SY, Kim NS, Lee HB, Moon SJ, Lee H. Comparison between treatment with aspirin alone and the combined treatment with aspirin with gammaglobulin in Kawasaki disease. J Korean Pediatr Soc 1990;33:1380-7
- Leem BY, Chung CS, Cha SH, Choi YM, Ahn CI. A comparative study of therapeutic effect of intravenous gammaglobulin plus aspirin versus aspirin alone in Kawasaki syndrome. J Korean Pediatr Soc 1989;32:1408-14
- Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996;128:146-9 https://doi.org/10.1016/S0022-3476(96)70447-X
- Kim NY, Chang CH, Lee DS, Kim DK, Choi SM, Kim WT. A clinical study of intravenous gammaglobulin retreatment in Kawasaki disease. J Korean Pediatr Soc 2000;43:223-8
- Hong DE, Lee KY, Han JW, Hwang SS, Lee KS. Treatment of intravenous immune-globulin resistant Kawasaki disease with corticosteroids. J Korean Pediatr Soc 1997;40:1453-7
- Kil HR. Recent advances in clinical field of Kawasaki disease. J Korean Pediatr Cardiol 2002;6:75-80
- Muta H, Ishii M, Furui J, Nakamura Y, Matsuishi T. Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease. Acta Paediatr 2006;95:189-93 https://doi.org/10.1080/08035250500327328
- Ogino H, Ogawa M, Harima Y, Kono S, Ohkuni H, Nishida M, et al. Clinical evaluation of gammaglobulin preparations for the treatment of Kawasaki disease. Prog Clin Biol Res 1987;250:555-6
- Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004;364:533-44 https://doi.org/10.1016/S0140-6736(04)16814-1
- Shim SY, Heo MY, Kim HS, Sonh S. High-dose intravenous immmune globulin retreatment in Kawasaki disease. J Korean Pediatr Soc 2002;45:1273-7
- Cho EY, Lee MH, Kang KS, No ES, Lee DJ, Choi MB, et al. Serum C-Reactive Protein as a predictor for cardiac sequelae in Kawasaki disease. J Korean Pediatr Cardiol 2002;6:90-5
- De Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 1998;133:254-8 https://doi.org/10.1016/S0022-3476(98)70229-X